ABUSCREEN FP FOR COCAINE METABOLITE— 510(k) K890885

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K890885 for ABUSCREEN FP FOR COCAINE METABOLITE, Substantially Equivalent on 1989-03-13. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code DIO
Advisory panel: Clinical Toxicology
Date received: 1989-02-21
Decision date: 1989-03-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montclair, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.